PR Newswire Clinical TrialsOriginal article
Ferronova announces preliminary results of MAGMAP, a 62-patient gastric and oesophageal cancer trial investigating lymph node mapping
Data Readoutpositivenanoparticle-based platformPositive
AI Analysis
Summary
Ferronova announced preliminary results from the MAGMAP trial, a 62-patient study evaluating a nanoparticle-based platform for lymph node mapping in gastric and oesophageal cancer patients. The trial assessed safety and feasibility of the medical technology platform.
Clinical Trial Data
Patients
62
Outcome Details
preliminary results from MAGMAP trial announced
Importance:5/10
Sentiment:
0.30
gastric canceroesophageal cancerlymph node mappingnanoparticlemedical technologypreliminary resultssafetyfeasibility
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 16, 2026 4:00 AM